Skip to main content
. 2012 Aug 28;20(12):2268–2281. doi: 10.1038/mt.2012.162

Figure 1.

Figure 1

Pre-existing neutralizing antibodies in Scottish cohort of patients. A dilution of 2.5% patient sera (n = 63) was used to inhibit adenovirus (Ad)-mediated luciferase transduction in HepG2 cells. Sera which inhibited >90% transduction compared to no serum control, was considered to be neutralizing, as described previously.15,50